Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Corbeau

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
AIDS (London, England)|September 20, 2017
Reversing HIV latency via sphingosine-1-phosphate receptor 1 signalingCharline Duquenne, Sandrine Gimenez, Adeline Guigues, et al.
Stem Cells (Dayton, Ohio)|October 1, 2010
Mesenchymal stem cell-dependent formation of heterotopic tendon-bone insertions (osteotendinous junctions)Sandra Shahab-Osterloh, Frank Witte, Andrea Hoffmann, et al.
Frontiers in Immunology|January 18, 2024
T4 apoptosis in the acute phase of SARS-CoV-2 infection predicts long COVIDRenaud Cezar, Lucy Kundura, Sonia André, et al.
The EMBO Journal|January 25, 2007
Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latencyIsaure du Chéné, Euguenia Basyuk, Yea-Lih Lin, et al.
Infectious Disease Reports|February 25, 2025
Immune Alterations and Viral Reservoir Atlas in SIV-Infected Chinese Rhesus MacaquesJulien A Clain, Morgane Picard, Henintsoa Rabezanahary, et al.
Scientific Reports|December 1, 2020
Identification of distinct immune activation profiles in adult humansRenaud Cezar, Audrey Winter, Delphine Desigaud, et al.
Frontiers in Immunology|November 7, 2022
Low perforin expression in CD8+ T lymphocytes during the acute phase of severe SARS-CoV-2 infection predicts long COVIDLucy Kundura, Renaud Cezar, Sonia André, et al.
Frontiers in Immunology|April 16, 2021
Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral TherapyMehwish Younas, Christina Psomas, Christelle Reynes, et al.
Diabetologia|July 2, 2020
Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding studyMichelle Rosenzwajg, Randa Salet, Roberta Lorenzon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 12, 2024
Low Percentage of Perforin-Expressing NK Cells during Severe SARS-CoV-2 Infection: Consumption Rather than Primary DeficiencyLucy Kundura, Renaud Cezar, Emma Ballongue, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
AIDS (London, England)|September 20, 2017
Reversing HIV latency via sphingosine-1-phosphate receptor 1 signalingCharline Duquenne, Sandrine Gimenez, Adeline Guigues, et al.
Stem Cells (Dayton, Ohio)|October 1, 2010
Mesenchymal stem cell-dependent formation of heterotopic tendon-bone insertions (osteotendinous junctions)Sandra Shahab-Osterloh, Frank Witte, Andrea Hoffmann, et al.
Frontiers in Immunology|January 18, 2024
T4 apoptosis in the acute phase of SARS-CoV-2 infection predicts long COVIDRenaud Cezar, Lucy Kundura, Sonia André, et al.
The EMBO Journal|January 25, 2007
Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latencyIsaure du Chéné, Euguenia Basyuk, Yea-Lih Lin, et al.
Infectious Disease Reports|February 25, 2025
Immune Alterations and Viral Reservoir Atlas in SIV-Infected Chinese Rhesus MacaquesJulien A Clain, Morgane Picard, Henintsoa Rabezanahary, et al.
Scientific Reports|December 1, 2020
Identification of distinct immune activation profiles in adult humansRenaud Cezar, Audrey Winter, Delphine Desigaud, et al.
Frontiers in Immunology|November 7, 2022
Low perforin expression in CD8+ T lymphocytes during the acute phase of severe SARS-CoV-2 infection predicts long COVIDLucy Kundura, Renaud Cezar, Sonia André, et al.
Frontiers in Immunology|April 16, 2021
Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral TherapyMehwish Younas, Christina Psomas, Christelle Reynes, et al.
Diabetologia|July 2, 2020
Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding studyMichelle Rosenzwajg, Randa Salet, Roberta Lorenzon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 12, 2024
Low Percentage of Perforin-Expressing NK Cells during Severe SARS-CoV-2 Infection: Consumption Rather than Primary DeficiencyLucy Kundura, Renaud Cezar, Emma Ballongue, et al.
Pageof 7